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Abstract 
In order to test whether SecY and SecE proteins constitute the SecA receptor inside out membrane vesicles where prepared from strains producing 
greatly different levels of these two proteins, and their SecA binding activity was quantitated. Substantial overproduction of SecE or SecY and SecE 
protems resulted in no increase or only 50% increase, respectively, in the number of high affinity SecA binding sites. These results suggest hat SecY 
and SecE proteins appear insufficient o constitute the primary SecA receptor. The existence of a cycle of SecA association with the inner membrane 
and its modulation by particular integral membrane proteins is discussed. 
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1. Introduction 
Genetic studies of protein export in Escherichiu coli 
have led to the identification of six genes, secA, secB, 
secD, secE, secF, and set Y, required for protein targeting 
to and translocation across the inner membrane [l]. In 
vitro protein translocation systems have been developed 
to begin to assign functions to the individual components 
of the translocation machinery [2]. SecA protein has been 
shown to be a membrane-associated ATPase that is es- 
sential for functional binding and translocation of pre- 
proteins across IMV [3]. SecA has been proposed to 
interact with the signal peptide and mature portions of 
the preprotein [4,5], SecB [6], inner-membrane anionic 
phospholipids [5,7], and SecY or SecY/SecE protein 
[6,8]. Interaction of an export-competent preprotein with 
SecA bound to IMV bearing functional SecY protein 
stimulates SecA’s translocation ATPase activity, which 
has been shown to be essential for both in vitro and in 
vivo protein translocation [9,10]. It has been suggested 
that this activity promotes successive cycles of of prepro- 
tein binding and insertion into the inner membrane 
[3,11]. Of the four integral membrane Set components, 
only SecY and SecE have been shown to be required for 
reconstitution of in vitro protein translocation activity, 
*Corresponding author. Fax: (1) (203) 344-7952. 
Abbreviations: IMV, inverted inner membrane vesicles; ISO-MV, in- 
side-out membrane vesicles; IPTG, isopropyl-~-o-thiogalactopyra- 
noside; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel elec- 
trophoresis. 
while SecD and SecF were non-functional in this assay 
[12-141. SecD may promote release of the translocated 
protein chain from the inner membrane, since addition 
of SecD antibodies to E. coli spheroplasts inhibited this 
process [ 151. 
SecA association with the inner membrane appears to 
be complex and dynamic. SecA was shown to exist in 
both peripheral and integral states of association with 
the inner membrane [7,16]. Initial binding of SecA to the 
inner membrane appears to be mediated by anionic 
phospholipids [5,7]. Subsequent interaction of SecA with 
SecY protein has been proposed based on the ability of 
high concentrations of SecA to suppress the protein 
translocation defect found normally for heat-inactivated 
set Y24( Ts) IMV as well as the requirement of transloca- 
tion ATPase for functional SecY protein [8,9]. Other 
studies led to the proposal that SecY or SecY/SecE pro- 
tein serves as the primary SecA receptor, since SecY 
antibody reduced the affinity of SecA for IMV 3-fold 
(but not the number of binding sites) and SecA addition 
to IMV afforded a 2-fold protection of SecY to proteol- 
ysis by trypsin [6]. However, antibody inhibition studies 
of membrane proteins have been shown to give rise to 
questionable results [ 17,181. Furthermore, recent studies 
demonstrated that high affinity binding of SecA to IMV 
required anionic phospholipids, which have been shown 
to promote SecA penetration into model membranes 
[19-211. Thus, the proposed interaction of SecA with 
SecY or SecY/SecE protein may occur only after pene- 
tration of SecA into the inner membrane. 
Since the identity of the SecA receptor remains uncer- 
tain, we decided to test directly whether SecY and SecE 
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proteins fulfill this function. We found that SecA-bind- 
ing activity did not increase in proportion to the in- 
creased content of SecY and SecE proteins present in 
membranes derived from overproducing strains [22], de- 
spite an increase in translocation ATPase and proton 
antiport activity [23], suggesting strongly that these pro- 
teins appear insufficient to constitute the primary SecA 
receptor. 
2. Materials and methods 
2.1. Medta and che~tcu~s 
LinA [24] and M63 minims medium [25] contained 50 &ml ampi- 
cillin and/or 30 pg/ml kanamycin where needed. Antibiotics, amino 
acids, IPTG, and most other common chemicals were obtained from 
Sigma Chemical Co. (St. Louis, MO). [‘*‘I]Donkey anti-rabbit IgG 
(Fab fragment) was purchased from Amersham Corp. (Arhngton 
Heights, IL). Nitrocellulose membrane for immunoblotting was ob- 
tained from Schleicher & Schuell (Keene, NH). 
2.2 Bacterial strams and plasmi& 
E. oli W3110 M25 (pMAN510, p~AN809) an o~zp~strain contam- 
ing plasmids with se& and secY, respectively. under the control of the 
fnc promoter was kindly provided by Dr. S. Mizushima (University of 
Tokyo) [22,26]. MC4100 (F- Ahc~169 araD136 relA rpsL thi) [27] 
contamma uMAN809 or uMAN.510 and ~uS12. containing the IacI 
gene [28],-was used for overproduction of’SecE or SecY, respectively. 
BL21QDE3) [29] containing either pT7secA [30] or pT7secA2 [31] was 
used for preparation of [3H]SecA protein. 
2 3. Preparation of pH]SecA protein and urea-treated ISO-MV 
Purified 13H]SecA protein was prepared either according to Cabelli 
1321 or with modification of the protein pu~fication procedure as de- 
scribed by Mitchell and Oliver [33]. For preparation of membranes 
strains were grown in LinA medium containing appropriate antibiotics 
and IPTG was added at mid-logarithmic phase growth for a period of 
2 h for induction of SecY or SecE. ISO-MV were prepared using the 
procedure of Matsushita et al. [34] with the following modifications. 
Cells were harvested by sedimentation. washed once m 50 mM Tris- 
HCI, pH 7.5, and resedimented. Cells were resuspended m 50 mM 
Tris-HCI, pH 7.5, 5 mM MgSO,, at 6 ml/g wet weight of cells, and 
DNase I was added to 10 &ml. The cell suspension was passed 
through the French pressure cell twice at 5,000 psi. Unbroken cells were 
removed by sedimentation at 10,000 x g for 10 min, and a membrane 
pellet was obtained after sedimentation at 120,000 x g for 2 h. Mem- 
branes were resuspended in 50 mM Tris-HCl, pH 7.5, 1 mM dithio- 
threitol, 10% glycerol, and 250 mM sucrose and stored at -80°C until 
use. In order to prepare urea-treated ISO-MV for SecA removal and 
Inactivation [35], the membrane pellet was resuspended in 5 M urea, 50 
mM Tris-HCI, pH 7.5, 1 mM dithiothreitol. 10% glycerol, and 250 mM 
sucrose and held on tee for 30 min. followed by resedimentation, wash- 
mg and final resuspension in 50 mM Tris-HCl, pH 7.5, 1 mM dithio- 
threitol, fO% glycerol, and 250 mM sucrose. 
-7.4. Bindmg assays 
Each lOOfl1 binding reaction contained varying amounts of f3H]SecA 
protein and 30 fig protein urea-treated ISO-MV or 100 mg protein 
ISO-MV in 50 mM Tris-OAc, pH 7.6,5 mM MgOAc, 1 mM spermid- 
ine. 8 mM putricine, 0.5 mg/ml BSA. Reactions were incubated on ice 
for 15 min, overlayed onto 100 ~10.2 M sucrose, 50 mM Trts-OAc, pH 
7.6.5 mM MgOAc, 1 mM spermidine, 8mM putricine, 0.5 mg/ml BSA 
and sedimented at 95,000 rpm for 30 min in a Sorvall RPlOO-AT2 rotor. 
Membrane pellets were resuspended in2% SDS, 125 mM Tris-HCI, pH 
6.8, 5% ~-mer~ptoethanol, 15% glycerol, 0.005% Bromophenol blue 
and the amount of [‘H]SecA was determmed by liquid scintillation 
counting. 
-7.5. SDS-PAGE and Western blotting 
SDS-PAGE utilized the discontinous ystem of Laemmh [36]. West- 
ern blot analysis of SecY and SecE employed a mixture of anti-SecY 
peptide and anti-SecE peptide antisera s the primary antibody and 0.5 
PCilml [“Qdonkey anti-rabbit IgG (Fab fragment) as the secondary 
antibody as described previously [7]. 
3. Results 
In order to determine whether SecY and SecE consti- 
tute the SecA receptor we utilized three strains: MC4100 
(pMAN809), MC4100 (pMAN510, pUS12), or W3110 
M25 (pMAN510, pMAN809) were used for overproduc- 
tion of SecE, SecY, or SecY and SecE proteins, respec- 
tively, using the regulated tat promoter 1221. Preparation 
of IMV from these strains revealed substantial cleavage 
and degradation of SecY protein, consistent with previ- 
ous observations by other investigators [37]. However. 
use of the protocol developed by Matsushita et al. [34] 
yielded ISO-MV preparations where SecY protein was 
largely intact as shown in Fig. 1. Furthermore, the SecY 
and SecE content of ISO-MV prepared from W3110 
M25 (pMAN510, pMAN809) was increased greatly after 
growth in the presence of IPTG, consistent with the prior 
estimate of a 50-fold and go-fold overproduction of SecY 
and SecE proteins, respectively, under these conditions 
[14]. The SecE content of ISO-MV prepared from 
MC4100 (pMAN809) was increased greatly also after 
growth in the presence of IPTG, while the SecY content 
ofISO-MV prepared from MC4100 (pMAN510, pUS12) 
showed little or no increase after growth in the presence 
of IPTG, consistent with the requirement for SecE over- 
production to achieve overproduction of SecY protein 
[22]. We performed binding assays of [3H]SecA on these 
ISO-MV preparations and the results are given in Fig. 
2. [3H]SecA binding activity increased no more than 2- 
fold in ISO-MV preparations of W3110 M25 
(pMAN510, pMAN809) that differed greatly in their 
SecY and SecE content (i.e. with or without IPTG induc- 
tion). ISO-MV preparations of MC4100 (pMAN809) 
that differed greatly in their SecE content showed very 
similar [3H]SecA binding activity. Identical conclusions 
were reached whether the high affinity or low alkity 
binding region of the curves was examined. Since our 
binding studies were performed with urea-treated mem- 
branes similar to previous studies 161, we considered the 
possibility that urea-treatment may damage the SecA 
receptor. Therefore, we repeated the binding studies 
using the same ISO-MV preparations prior to urea-treat- 
ment. The results are shown in Fig. 3. [3H]SecA binding 
activity was decreased substantially in this case com- 
pared to the comparable urea-treated ISO-MV prepara- 
tions, consistent with the idea that endogenous mem- 
brane associated SecA protein [7] or some other mem- 
brane associated component removed by urea depressed 
[3H]SecA binding activity. However, little difference in 
[“H]SecA binding activity was seen for ISO-MV prepara- 
tions that differed greatly in either SecE or SecY and 
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Fig. 1. SecY and SecE protein content of ISO-MV. Urea-treated ISO-MV were prepared from the strains Indicated with or without IPTG induction 
as described in section 2. (A) 50 pg protein of each ISO-MV was analyzed by SDS-PAGE and staining with Coomassie brilliant blue R or (B) 30 
pg protein of each ISO-MV was analyzed by Western blotting. Molecular weight standards of 66 kDa, 31 kDa, 18 kDa, and 14 kDa and the positions 
of SecY and SecE proteins are indicated. 
SecE content. These results suggest hat damage of SecY 
or SecE by urea-treatment is not a likely explanation for 
the failure to observe an increase in SecA binding activity 
in this case. This interpretation is consistent with the 
maintenance of in vitro protein translocation activity of 
membranes after treatment with urea [16,35,38]. 
The data in Figs. 2 and 3 were used to calculate & 
values of SecA protein for different ISO-MV prepara- 
tions as well as to determine the number of high affinity 
binding sites present in each case. The results are pre- 
sented in Table 1. In general, the & values obtained were 
5-9-fold higher than the previous estimate of 40 r&I, but 
the number of high affinity binding sites was similar to 
the value of 140 pmol/mg membrane protein obtained 
previously [6]. The reason for the discrepancy in the 
former measurement is unclear, but may relate to differ- 
ences in the strains employed, membrane preparation 
methodology, or SecA binding assays. Urea-treated ISO- 
MV preparations with greatly increased SecY and SecE 
content showed only a 50% increase in high affinity bind- 
ing sites and a 50% decrease in & value compared to 
urea-treated ISO-MV from the uninduced strain. These 
same ISO-MV preparations prior to urea-treatment had 
similar & and binding site values despite their difference 
in SecY and SecE content. However, they displayed only 
10% of the number of high affinity binding sites found 
for their urea-treated counterparts. Urea-treated ISO- 
MV preparations with greatly increased SecE content 
showed similar & and binding site values compared to 
ISO-MV preparations with normal SecE content (e.g. 
compare MC4100 (pMAN809) with MC4100 
(pMAN510, pUSl2)), indicating that overproduction of 
SecE alone did not lead to an increase in membrane 
binding activity of SecA protein either. 
4. Discussion 
Since previous investigations either did not address the 
question of whether SecA’s interaction with SecY or 
SecE was primary or were based on marginal effects, we 
investigated this question directly by comparing SecA 
binding activity of ISO-MV preparations differing 
greatly in their content of these integral membrane pro- 
teins. ISO-MV preparations that differed greatly in their 
SecE content showed similar SecA binding activity, while 
ISO-MV preparations with greatly increased SecY and 
SecE content showed only a 50% increase in high affinity 
SecA binding sites compared to the control and an actual 
decrease in SecA affinity. Kawasaki et al. [23] showed 
that overproduction of SecY and SecE proteins in this 
strain led to a 5-fold increase in SecA-dependent translo- 
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Rg. 2. SecA binding activity of urea-treated ISO-MV differing in SecY and SecE content. Binding assays of [3H]SecA protein with urea-treated 
ISO-MV prepared from the strains indicated grown with or without IPTG induction were performed as described in section 2. (A,B) Both direct 
plots and (CD) Scatchard plots of the data are shown. The data for W3110 M2.5 (pMANSl0. pMAN809) are representative of three experiments, 
while that for MC4100 (pMAN510. pUS12) and MC4100 (pMAN809) are representative of two experiments. 
cation ATPase activity as well as an increase in prepro- 
tein-dependent proton antiport activity, both of which 
have been shown previously to be measures of SecY or 
SecY/SecE protein activity [9,393. These results, com- 
bined with a report that protein translocation has been 
reconstituted from the overproduced SecY and SecE 
proteins in this strain [13], argues strongly that the over- 
produced proteins were active in this case. Taken to- 
Table 1 
Summary of Scatchard analysis of SecA binding activity of ISO-MV differing in SecY and SecE content 
ISO-MV type IPTG Urea- Kd @Ml 
treatment 
Binding sites (pmolimg 
membrane protein) 
W3100 M25 (pMAN510, pMAN809) 
W3100 M25 (pMANSl0, pMAN809) 
W3100 M25 (pMAN510, pMAN809) 
W3100 M2.5 (pMANSl0, pMAN809) 
MC4100 (pMAN510, pUS12) 
MC41iXl fnMANX091 
f f 300 274 
_. + 200 187 
+ _ 283 28 
_ 263 20 
+ + 352 192 
+ + 350 116 
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Fig. 3. SecA binding activity of ISO-MV differing in SecY and SecE 
content. Binding assays of [3H]SecA protein with ISO-MV prepared 
from W3110 M25 (pMAN510, pMAN809) grown with or without 
IPTG induction were performed as described in section 2. (A) Both 
direct plots and (B) Scatchard plots of the data are shown. 
gether, these data suggest strongly that SecY and SecE 
proteins appear insufficient to constitute the SecA pri- 
mary receptor. 
There have been several recent reports indicating the 
existence of at least three additional integral membrane 
proteins that may play roles in protein secretion. A pro- 
tein termed band 1 was found in a complex with SecYl 
SecE protein, where it appears to promote stabilization 
of this complex, since no increase in the amount of SecYl 
SecE complex was detected during overproduction of 
these latter proteins [37]. Our data are in agreement with 
this result (Kim and Oliver, unpublished results), al- 
though it is difficult to rationalize the requirement of 
elevated SecE levels for SecY overproduction unless 
these two proteins form a complex in vivo albeit a labile 
one. The failure of overproduced SecY and SecE pro- 
teins to stably oligomerize into a SecA receptor could 
explain our negative results, although the overproduced 
proteins have been shown to be active by a number of 
criteria [13,23]. Reconstitution of another integral mem- 
brane protein, ~12, into proteoliposomes containing 
SecY and SecE has been reported to cause more than a 
20-fold increase in Set-dependent in vitro protein 
translocation activity [40]. Finally, a third integral mem- 
brane protein, Ydr, was isolated as a multicopy suppres- 
sor of a dominant-negative see Y mutant, and it displayed 
synthetic lethality with the secY24(Tsf allele as well as 
allowing SecY overproduction [41]. Whether any of these 
newly identified integral membrane proteins play pri- 
mary or secondary roles in SecA association with the 
inner membrane will require a direct study to address 
this point. We have found recently that SecA localization 
is altered dramatically in a strain that carries a plasmid 
borne copy of the se& se&’ operon [42], since only the 
integral membrane form of SecA protein (resistant to 
extraction by sodium carbonate) was detected in this case 
(Y. Kim, T. Rajapandi, and D. Oliver, manuscript in 
preparation). This result is consistent with the recent 
report that the integral membrane form of SecA protein 
was fully active in promoting in vitro protein transloca- 
tion [16]. Analysis of SecA binding activity of urea- 
treated ISO-MV from this strain showed an increased 
affinity but decreased number of high affinity sites (153 
nM and 67 pmol/mg membrane protein, respectively). 
These data suggest hat SecA binding, penetration, and 
release from the inner membrane is complex and will 
require a thorough analysis to reveal the biochemical 
interactions involved. Given the large number of integral 
membrane proteins that have been proposed to play 
roles in protein secretion, a careful analysis of this prob- 
lem will be required to unambiguously identify the SecA 
receptor and to elucidate which interactions with SecA 
are primary versus secondary. 
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